Endocrine Abstracts

Background: Woman with Polycystic Ovarian Syndrome (PCOS) are at risk of developingmetabolic syndrome (MetS), insulin resistance, dyslipidemia, Type 2 Diabetes and Cardiovascular Disease. Atherogenic dyslipidemia occurs in > 70% of women with PCOS which includes high fasting plasma TG, LDL-C, non-HDL-C or ApoB, and low HDL-C. In addition to diet and lifestyle as the first-line intervention, metformin is commonly prescribed for impaired glucose sensitivity. However, metform...

Background: The high prevalence of chronic disease urges for new ways of working with our patients as active members of the health care team to better design processes for ongoing supportive treatment. Our Division of Endocrinology & Metabolism at the University of Alberta prioritized the need to improve care for those living with adrenal insufficiency (AI). We have worked with AI patient partners to address learning needs and priorities of our patients, their caregivers, ...